Cargando…

An RNA Interference Lethality Screen of the Human Druggable Genome to Identify Molecular Vulnerabilities in Epithelial Ovarian Cancer

Targeted therapies have been used to combat many tumor types; however, few have effectively improved the overall survival in women with epithelial ovarian cancer, begging for a better understanding of this deadly disease and identification of essential drivers of tumorigenesis that can be targeted e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sethi, Geetika, Pathak, Harsh B., Zhang, Hong, Zhou, Yan, Einarson, Margret B., Vathipadiekal, Vinod, Gunewardena, Sumedha, Birrer, Michael J., Godwin, Andrew K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467214/ https://www.ncbi.nlm.nih.gov/pubmed/23056589 http://dx.doi.org/10.1371/journal.pone.0047086

Ejemplares similares

A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer
por: Pathak, Harsh B., et al.
Publicado: (2015)

Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer
por: Vathipadiekal, Vinod, et al.
Publicado: (2012)

Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle Trafficking
por: Brew, Tom, et al.
Publicado: (2021)

Systematic Identification of Druggable Epithelial–Stromal Crosstalk Signaling Networks in Ovarian Cancer
por: Yeung, Tsz-Lun, et al.
Publicado: (2018)

Oligomeric protein interference validates druggability of aspartate interconversion in Plasmodium falciparum
por: Batista, Fernando A., et al.
Publicado: (2019)

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis
por: Sosulski, Amanda, et al.
Publicado: (2016)

Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck Cancer
por: Deneka, Alexander Y., et al.
Publicado: (2020)

Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer
por: Seguin, Laetitia, et al.
Publicado: (2018)

Novel Insights into RAD52’s Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies
por: Balboni, Beatrice, et al.
Publicado: (2023)

Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer
por: Choi, Stephen Y. C., et al.
Publicado: (2022)

Global gene expression changes in liver following hepatocyte nuclear factor 4 alpha deletion in adult mice
por: Gunewardena, Sumedha, et al.
Publicado: (2015)

Nutrient restriction synergizes with retinoic acid to induce mammalian meiotic initiation in vitro
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer
por: Francavilla, Chiara, et al.
Publicado: (2017)

HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities
por: Koeneke, Emily, et al.
Publicado: (2015)

Chemoproteomics of an Indole-Based Quinone Epoxide Identifies Druggable Vulnerabilities in Vancomycin-Resistant Staphylococcus aureus
por: Kulkarni, Amogh, et al.
Publicado: (2019)

Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient Cells
por: Bougen-Zhukov, Nicola, et al.
Publicado: (2019)

Etiology and Pathogenesis of Epithelial Ovarian Cancer
por: Mok, Samuel C., et al.
Publicado: (2007)

E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function
por: Godwin, Tanis D., et al.
Publicado: (2018)

mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability
por: Gremke, Niklas, et al.
Publicado: (2020)

The Druggable Pocketome of Corynebacterium diphtheriae: A New Approach for in silico Putative Druggable Targets
por: Hassan, Syed S., et al.
Publicado: (2018)

Exploring Whether Iron Sequestration within the CNS of Patients with Alzheimer’s Disease Causes a Functional Iron Deficiency That Advances Neurodegeneration
por: LeVine, Steven M., et al.
Publicado: (2023)

Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model
por: McCann, Christopher K., et al.
Publicado: (2011)

KRAS: Druggable at Last
por: Herzberg, Benjamin O, et al.
Publicado: (2023)

FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers
por: Mesquita, Katia A., et al.
Publicado: (2021)

DGIdb - Mining the druggable genome
por: Griffith, Malachi, et al.
Publicado: (2013)

Cysteine metabolic circuitries: druggable targets in cancer
por: Bonifácio, Vasco D. B., et al.
Publicado: (2020)

Cell-Specific Post-Transcriptional Regulation of γ-Synuclein Gene by Micro-RNAs
por: Surgucheva, Irina, et al.
Publicado: (2013)

Analysis of lncRNA-miRNA-mRNA Interactions in Hyper-proliferative Human Pulmonary Arterial Smooth Muscle Cells
por: Chinnappan, Mahendran, et al.
Publicado: (2019)

Transcriptomic data showing differentially expressed genes between Notch3 and Notch4 deleted mice
por: Sharma, Madhulika, et al.
Publicado: (2021)

Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer
por: Raghavan, Rama, et al.
Publicado: (2016)

Synthetic Lethality in Ovarian Cancer
por: Chandrasekaran, Akshaya, et al.
Publicado: (2021)

Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers
por: Ali, Reem, et al.
Publicado: (2021)

Highly expressed SERCA2 triggers tumor cell autophagy and is a druggable vulnerability in triple-negative breast cancer
por: Fan, Minmin, et al.
Publicado: (2022)

Druggable Drivers of Lung Cancer
por: Fawdar, Shameem, et al.
Publicado: (2013)

Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality
por: Benfatto, Salvatore, et al.
Publicado: (2021)

Developing a genetic signature to predict drug response in ovarian cancer
por: Hyter, Stephen, et al.
Publicado: (2017)

Recent efforts for drug identification from phytochemicals against SARS-CoV-2: Exploration of the chemical space to identify druggable leads
por: Joshi, Gaurav, et al.
Publicado: (2021)

Exposure-dependent variation in cryolite induced lethality in the non-target insect, Drosophila melanogaster
por: Podder, Sayanti, et al.
Publicado: (2014)

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
por: Stany, Michael P., et al.
Publicado: (2011)

ChIPing the cistrome of PXR in mouse liver
por: Cui, Julia Yue, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_d0q0t66enculvp714ldv0n66dm